Literature DB >> 18081560

Leptin deficiency per se dictates body composition and insulin action in ob/ob mice.

A M van den Hoek1, B Teusink, P J Voshol, L M Havekes, J A Romijn, H Pijl.   

Abstract

Obese humans are often insulin- and leptin resistant. Since leptin can affect glucose metabolism, it is conceivable that a lack of leptin signal transduction contributes to insulin resistance. It remains unclear whether leptin affects glucose metabolism via peripheral and/or central mechanistic routes. In the present study, we aimed: (i) to determine the relative contributions of lack of leptin signal transduction and adiposity to insulin resistance and (ii) to establish the impact of central leptin action on glucose metabolism. To address the first point, ob/ob mice were subjected to severe calorie restriction, so that their body weight became similar to that of wild-type mice. Insulin sensitivity was measured in obese ob/ob, lean (food restricted) ob/ob and lean, weight-matched wild-type mice. To address the second point, leptin (or vehicle) was i.c.v. infused to the lateral cerebral ventricle of ob/ob mice and insulin sensitivity was determined. Hyperinsulinaemic euglyceamic clamps were used to quantify insulin sensitivity. Food restriction barely affected body composition, although it profoundly curtailed body weight. Insulin suppressed hepatic glucose production (HGP) to a greater extent in lean ob/ob than in obese ob/ob mice, but its impact remained considerably less than in wild-type mice (% suppression: 11.8 +/- 8.9 versus 1.3 +/- 1.1 versus 56.6 +/- 13.0%/nmol, for lean, obese ob/ob and wild-type mice, respectively; P < 0.05). The insulin-mediated glucose disposal (GD) of lean ob/ob mice was also in between that of obese ob/ob and wild-type mice (37.5 +/- 21.4 versus 25.1 +/- 14.6 versus 59.6 +/- 17.3 mumol/min/kg/nmol of insulin, respectively; P < 0.05 wild-type versus obese ob/ob mice). Leptin infusion acutely enhanced both hepatic insulin sensitivity (insulin-induced inhibition of HGP) and insulin-mediated GD (9.1 +/- 2.4 versus 5.0 +/- 2.7%/nmol of insulin, and 25.6 +/- 5.6 versus 13.6 +/- 4.8 mumol/min/kg/nmol of insulin, respectively; P < 0.05 for both comparisons) in ob/ob mice. Both a lack of leptin signals and adiposity may contribute to insulin resistance in obese individuals. Diminution of central leptin signalling can critically affect glucose metabolism in these individuals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18081560     DOI: 10.1111/j.1365-2826.2007.01626.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  19 in total

1.  High levels of dietary stearate promote adiposity and deteriorate hepatic insulin sensitivity.

Authors:  Sjoerd Aa van den Berg; Bruno Guigas; Silvia Bijland; Margriet Ouwens; Peter J Voshol; Rune R Frants; Louis M Havekes; Johannes A Romijn; Ko Willems van Dijk
Journal:  Nutr Metab (Lond)       Date:  2010-03-27       Impact factor: 4.169

Review 2.  Minireview: CNS Mechanisms of Leptin Action.

Authors:  Jonathan N Flak; Martin G Myers
Journal:  Mol Endocrinol       Date:  2015-10-20

Review 3.  Central insulin and leptin-mediated autonomic control of glucose homeostasis.

Authors:  Joseph S Marino; Yong Xu; Jennifer W Hill
Journal:  Trends Endocrinol Metab       Date:  2011-04-12       Impact factor: 12.015

Review 4.  A role for leptin-regulated neurocircuitry in subordination stress.

Authors:  Jonathan N Flak
Journal:  Physiol Behav       Date:  2016-11-22

5.  The insulin sensitizing effect of topiramate involves KATP channel activation in the central nervous system.

Authors:  C P Coomans; J J Geerling; S A A van den Berg; H C van Diepen; N Garcia-Tardón; A Thomas; J P Schröder-van der Elst; D M Ouwens; H Pijl; P C N Rensen; L M Havekes; B Guigas; J A Romijn
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

Review 6.  Central leptin receptor action and resistance in obesity.

Authors:  Christian Bjørbaek
Journal:  J Investig Med       Date:  2009-10       Impact factor: 2.895

Review 7.  Leptin revisited: its mechanism of action and potential for treating diabetes.

Authors:  Roberto Coppari; Christian Bjørbæk
Journal:  Nat Rev Drug Discov       Date:  2012-09       Impact factor: 84.694

8.  Sepsis induced changes of adipokines and cytokines - septic patients compared to morbidly obese patients.

Authors:  Andreas Hillenbrand; Uwe Knippschild; Manfred Weiss; Hubert Schrezenmeier; Doris Henne-Bruns; Markus Huber-Lang; Anna M Wolf
Journal:  BMC Surg       Date:  2010-09-09       Impact factor: 2.102

9.  Leptin-dependent control of glucose balance and locomotor activity by POMC neurons.

Authors:  Lihong Huo; Kevin Gamber; Sarah Greeley; Jose Silva; Nicholas Huntoon; Xing-Hong Leng; Christian Bjørbaek
Journal:  Cell Metab       Date:  2009-06       Impact factor: 27.287

Review 10.  Central nervous system regulation of organismal energy and glucose homeostasis.

Authors:  Martin G Myers; Alison H Affinati; Nicole Richardson; Michael W Schwartz
Journal:  Nat Metab       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.